1. RESPONSE‐ADAPTED TREATMENT WITH NIVOLUMAB AND BRENTUXIMAB VEDOTIN IN YOUNG PATIENTS WITH RELAPSED/REFRACTORY CLASSICAL HODGKIN LYMPHOMA: CHECKMATE 744 SUBGROUP ANALYSES. (12th June 2019) Authors: Kelly, K.M.; Daw, S.; Mauz‐Körholz, C.; Mascarin, M.; Michel, G.; Cooper, S.; Beishuizen, A.; Leger, K.J.; Garaventa, A.; Buffardi, S.; Brugières, L.; Harker‐Murray, P.; Cole, P.D.; Drachtman, R.A.; Manley, T.; Francis, S.; Sacchi, M.; Leblanc, T. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 56 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗